Matinas BioPharma面临纽约证券交易所关于股权短缺的通知;直到2027年才能遵守

2026-06-27 05:38

Matinas BioPharma (MTNB) announced on Friday that it received a notice from NYSE American for not meeting the exchange's minimum shareholder equity requirement.
The company's shareholder equity fell to $3.02M in March 2026, below the required $4M threshold after posting losses for the past five years.
The NYSE accepted the company's plan to resolve the issue and gave it until October 2, 2027, to regain compliance.
Moreover, the shares could face delisting in the future if the company fails to improve its financial position.
The notice does not impact the company's daily operations or stock trading for now.
Source: Press Release

More on Matinas Biopharma